P L Ogra. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Age FactorsAntibodiesChildHumansHypersensitivity, DelayedInfantInfant, NewbornInfluenza Vaccines/therapeutic useInfluenza, Human/immunologyLymphocytes/immunologyMeasles/immunologyMeasles Vaccine/therapeutic useMeasles virus/immunologyMumps/immunologyMumps Vaccine/therapeutic useMumps virus/immunologyOrthomyxoviridae/immunologyPoliovirus/immunologyPoliovirus Vaccine, Inactivated/therapeutic useRubella/immunologyRubella Vaccine/therapeutic useRubella virus/immunologySmallpox/immunologySmallpox VaccineViral Vaccines/therapeutic useVirus Diseases/immunologygamma-Globulins
Substances: See more » AntibodiesInfluenza VaccinesMeasles VaccineMumps VaccinePoliovirus Vaccine, InactivatedRubella VaccineSmallpox VaccineViral Vaccinesgamma-Globulins
Year: 1970 PMID: 4099208 DOI: 10.1007/BF02822936
Source DB: PubMed Journal: Indian J Pediatr ISSN: 0019-5456 Impact factor: 1.967